Octreotide acetate

Modify Date: 2024-01-02 15:56:33

Octreotide acetate Structure
Octreotide acetate structure
Common Name Octreotide acetate
CAS Number 83150-76-9 Molecular Weight 1019.239
Density 1.4±0.1 g/cm3 Boiling Point 1447.2±65.0 °C at 760 mmHg
Molecular Formula C49H66N10O10S2 Melting Point N/A
MSDS Chinese USA Flash Point 829.1±34.3 °C

 Use of Octreotide acetate


Octreotide is a somatostatin analog that binds to the somatostatin receptor, mainly subtypes 2, 3, and 5, increases Gi activity, and reduces intracellular cAMP production.

 Names

Name Octreotide acetate
Synonym More Synonyms

 Octreotide acetate Biological Activity

Description Octreotide is a somatostatin analog that binds to the somatostatin receptor, mainly subtypes 2, 3, and 5, increases Gi activity, and reduces intracellular cAMP production.
Related Catalog
In Vitro Octreotide reverses the PA-induced alterations in Akt and GSK3β phosphorylation and expression of GS mRNA in HepG2 cells[1].
In Vivo Octreotide significantly lowers the plasma glucose levels in the obese rats of the HFD group. Octreotide intervention significantly decreases the serum insulin concentration; however, there is no marked reduction in serum TG, TC, FFA, ALT and AST levels. Octreotide significantly inhibits the HOMA index. Octreotide decreases ipGTT and ipITT AUCs, but not significantly. Octreotide improves fat degeneration in rats with HFD-induced obesity and lipid droplet accumulation in PA-treated HepG2 cells. Octreotide promotes the phosphorylation of Akt and GSK3β and the expression of GS mRNA in rats with HFD-induced obesity[1]. Octreotide reduces body weight and wet kidney weight compared with the vehicle-treated (CONT) group. PAS and Octreotide/PAS treatment decrease cAMP levels, but Octreotide alone does not in PCK rats. In the Octreotide/PAS group, there are a significantly fewer pS6-positive cells than in the PAS alone group[2].
Animal Admin AMale PCK rats (n = 24) are assigned randomly to 1 of 4 groups (n = 6 per group): treatment by subcutaneous injection every 4 weeks treatment with 8 mg/kg Octreotide-LAR alone, 8 mg/kg PAS-LAR alone, co-application of 8 mg/kg Octreotide and 8 mg/kg PAS, or vehicle (microparticles liquid; CONT) from 4 to 16 weeks of age. The vehicle contains copolymer microparticles with polylactic-co-glycolic acid (PLGA). In 4- and 15-week-old conscious rats, heart rate (HR), diastolic blood pressure (DBP), and systolic blood pressure (SBP) are determined using a tail-cuff sphygmomanometer. Twenty-four-hour urine volume and food consumption are measured using metabolic cages after 15.5 weeks of age. After body weight measurement, the animals are anesthetized with sodium pentobarbital at 16 weeks of age, and the kidneys and liver are removed rapidly, causing lethal exsanguination. Total wet kidney weight and wet liver weight are measured, and blood samples are collected for measurements of serum urea nitrogen (SUN), aspartate amino transferase (AST), alanine aminotransferase (ALT), insulin-like growth factor-1 (IGF-1), glucose, insulin, glucagon, and cortisol.
References

[1]. Wang XX, et al. Effects of octreotide on hepatic glycogenesis in rats with high fat diet?induced obesity. Mol Med Rep. 2017 Jul;16(1):109-118

[2]. Kugita M, et al. Beneficial effect of combined treatment with octreotide and pasireotide in PCK rats, an orthologous model of human autosomal recessive polycystic kidney disease. PLoS One. 2017 May 18;12(5):e0177934.

 Chemical & Physical Properties

Density 1.4±0.1 g/cm3
Boiling Point 1447.2±65.0 °C at 760 mmHg
Molecular Formula C49H66N10O10S2
Molecular Weight 1019.239
Flash Point 829.1±34.3 °C
Exact Mass 1018.440491
PSA 382.82000
LogP 0.77
Vapour Pressure 0.0±0.3 mmHg at 25°C
Index of Refraction 1.673
Storage condition −20°C
Water Solubility H2O: soluble

 Safety Information

Personal Protective Equipment Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
RIDADR NONH for all modes of transport
HS Code 3004909090

 Synthetic Route

~%

Octreotide acetate Structure

Octreotide acetate

CAS#:83150-76-9

Literature: Journal of Organic Chemistry, , vol. 68, # 3 p. 1161 - 1162

 Precursor & DownStream

Precursor  1

DownStream  0

 Customs

HS Code 3004909090

 Articles155

More Articles
Frequency-dependent, cell type-divergent signaling in the hippocamposeptal projection.

J. Neurosci. 34(35) , 11769-80, (2014)

Hippocampal oscillations are critical for information processing, and are strongly influenced by inputs from the medial septum. Hippocamposeptal neurons provide direct inhibitory feedback from the hip...

Direct effect of incretin hormones on glucose and glycerol metabolism and hemodynamics.

Am. J. Physiol. Endocrinol. Metab. 308(5) , E426-33, (2015)

The objective of this study was to assess the insulin-independent effects of incretin hormones on glucose and glycerol metabolism and hemodynamics under euglycemic and hyperglycemic conditions. Young,...

Evaluation of cobalt-labeled octreotide analogs for molecular imaging and auger electron-based radionuclide therapy.

J. Nucl. Med. 55(8) , 1311-6, (2015)

The somatostatin receptor, which is overexpressed by many neuroendocrine tumors, is a well-known target for molecular imaging and peptide receptor radionuclide therapy. Recently, (57)Co-labeled DOTATO...

 Synonyms

Octreotode Acetate
Octreotide
Sandostatin<*>
SMS 201-995
OCTREOTIDE ACETATE (GMP)
Octreotideacetate
1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane-4-carboxamide, 10-(4-aminobutyl)-19-[[(2R)-2-amino-1-oxo-3-phenylpropyl]amino]-7-[(1R)-1-hydroxyethyl]-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-16-(phenylmethyl)-, (4R,7S,10S,13R,16S,19R)-
ctreotide
H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-L-threoninol acetate salt (Disulfide bond)
MFCD00871400
D-Phe-Cys(1)-Phe-D-Trp-Lys-Thr-Cys(1)-N-[(1R,2R)-1-(Hydroxymethyl)-2-hydroxypropyl]-NH2
Phe-c(Cys-Phe-Trp-Lys-Thr-Cys)-CH(CH2OH)-CH(OH)-CH3
Longastatin
OXTREOTIDE
(4R,7S,10S,13R,16S,19R)-10-(4-Aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(D-phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
DARAMONOL
Sandostatin
Ocetreotide,Acetate
Top Suppliers:I want be here





Get all suppliers and price by the below link:

Octreotide acetate suppliers


Price: $50/1mg

Reference only. check more Octreotide acetate price